EUS & ablation products

We’re committed to partnerships with interventional radiologists, pathologists, oncologists, surgeons, and the GI community for proactive GI care.

Featured product

SharkCore - Risk Information: Those associated with gastrointestinal endoscopy include, but are not limited to: Perforation, hemorrhage, aspiration, fever, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest, infection, allergic reaction to medication, damage to blood vessels, nerve damage, and acute pancreatitis. Those associated with EUS needle biopsy include but are not limited to: bleeding, pain, death, peritonitis, infection / bacteremia, tumor seeding of the needle tract, and needle fracture requiring intervention for removal. Please refer to the product user manual or www.medtronic.com/gi for detailed information.

Beacon - Risk Information: Procedural risks associated with gastrointestinal endoscopy include, but are not limited to: perforation, hemorrhage, aspiration, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest, infection/fever, bacteremia, allergic reaction to medication, damage to blood vessels, nerve damage, tumor seeding of the needle tract, and acute pancreatitis. For Beacon FNF Only: Those associated with EUS fiducial placement include, but are not limited to: improper fiducial placement, fiducial migration, infection/fever, allergic reaction, local inflammatory foreign body response, minor bleeds, pain, pancreatitis, and needle fracture requiring intervention for removal. Please refer to the product user manual for detailed information.

Barrx - Risk assessment: Risk Information: The following are transient side effects that may be expected after treatment: chest pain, difficulty swallowing, painful swallowing, throat pain, and/or fever. Potential complications include mucosal laceration, minor or major bleeding, endoscopic clipping to manage mucosal laceration or bleeding, perforation of the stomach, esophagus, or pharynx, surgery to manage perforation, esophageal stricture, endoscopic dilation to manage stricture, pleural effusion, transfusion secondary to major bleeding, cardiac arrhythmia, aspiration, infection and death.

Emprint - Risk assessment: The Emprint™ ablation system is intended for use in percutaneous, laparoscopic, and intraoperative coagulation (ablation) of soft tissue, including partial or complete ablation of non-resectable liver tumors. The Emprint™ system is not intended for use in cardiac procedures. Microwave ablation procedures are not recommended for patients with cardiac pacemaker or other implanted electronic devices. Potential risks have not been evaluated. Microwave ablation procedures are not recommended for pregnant patients. Potential risks to the patient and/or fetus have not been established.